Literature DB >> 21893325

Terpenoids and phenethyl glucosides from Hyssopus cuspidatus (Labiatae).

Megumi Furukawa1, Mitsuko Makino, Emika Ohkoshi, Taketo Uchiyama, Yasuo Fujimoto.   

Abstract

Monoterpenoids (3 and 4), sesquiterpenoid (2), diterpenoid (1) and four phenethyl glucosides (5-8), together with fourteen known compounds, were isolated from the whole herb of Hyssopus cuspidatus. Their structures were determined by spectroscopic means. The abietane-type diterpenoids (1, 9, 10), rosmarinic acid (15) and salvigenin (17) inhibited leukotriene (LT) C(4) secretion from primary alveolar cells of Wistar rats.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21893325     DOI： 10.1016/j.phytochem.2011.07.008

Source DB:  PubMed          Journal:  Phytochemistry        ISSN： 0031-9422            Impact factor:   4.072


  4 in total

Review 1.  A Comprehensive Review of Rosmarinic Acid: From Phytochemistry to Pharmacology and Its New Insight.

Authors:  Huaquan Guan; Wenbin Luo; Beihua Bao; Yudan Cao; Fangfang Cheng; Sheng Yu; Qiaoling Fan; Li Zhang; Qinan Wu; Mingqiu Shan
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

2.  Cytotoxic Terpenoids from the Roots of Dracocephalum taliense.

Authors:  Yanyan Deng; Juan Hua; Wenjia Wang; Zhonglang Zhan; Anqi Wang; Shihong Luo
Journal:  Molecules       Date:  2017-12-27       Impact factor: 4.411

3.  Discovery of Phenolic Glycoside from Hyssopus cuspidatus Attenuates LPS-Induced Inflammatory Responses by Inhibition of iNOS and COX-2 Expression through Suppression of NF-κB Activation.

Authors:  Xingyu Liu; Jie Su; Geng Wang; Lihua Zheng; Guannan Wang; Ying Sun; Yongli Bao; Shuyue Wang; Yanxin Huang
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

4.  Network Pharmacology-Based Analysis of the Underlying Mechanism of Hyssopus cuspidatus Boriss. for Antiasthma: A Characteristic Medicinal Material in Xinjiang.

Authors:  Rongchang Liu; Yan Mao; Zhengyi Gu; Jinhua He
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-29       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.